#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial dilated cardiomyopathy Philadelphia chromosome positive Growth hormone deficiency Wiskott-Aldrich syndrome Pericarditis Malignant oligodendroglioma Bone marrow disorder Autoimmune haemolytic anaemia Cytokine release syndrome Muscular dystrophy Acquired C1 inhibitor deficiency Hereditary angioedema with C1 esterase inhibitor deficiency Neuroendocrine cell hyperplasia of infancy Myotonic dystrophy Liposarcoma metastatic More trials…

    Learn about Rare Diseases

    Alexander disease – Trials in Disease Wolfram syndrome – Diagnostics Haemophagocytic lymphohistiocytosis – Diagnostics Erdheim-Chester disease Loeys-Dietz syndrome – Basic Information CADASIL – Diagnostics Systemic mastocytosis – Basic Information Bronchiolitis obliterans syndrome – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Trials in Disease Skin angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Sulfate Fitusiran SUMATRIPTAN Dexamethasone Isonicotinate Betibeglogene Autotemcel Rivaroxaban Narsoplimab Abc-16F-116 Bi 765845 Fluorometholone Exl01 Pegunigalsidase Alfa Itacitinib Cytarabine Crgd-Zw800-1 Apocynin Bepirovirsen Panitumumab Ciclesonide Lacosamide More therapies…

    Learn about Your Condition

    Hypotransferrinaemia Chronic disease Spinal pain Adenocarcinoma pancreas Encephalitis Japanese B Endometrial cancer metastatic Partial seizures Systemic infection Tinnitus Behavioural addiction Malignant melanoma stage IV Frostbite Procedural headache Dermatitis atopic Diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    Austria Belgium France Germany Italy Poland +2

  • Study of ponsegromab for patients with cancer cachexia and elevated GDF-15 levels

    Not recruiting

    2 1
    Investigated Diseases:
    • Cachexia
    Investigated Drugs:
    • Ponsegromab
    Bulgaria Poland Slovakia Spain

  • Study on Evolocumab for Reducing Cardiovascular Events in Patients with Acute Myocardial Infarction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Evolocumab
    Sweden

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Long-Term Effects of Lerodalcibep for Lowering Cholesterol in Patients with Familial Hypercholesterolemia or Cardiovascular Disease Risks

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Lerodalcibep
    France Germany Norway Spain

  • Study on Gene Therapy with VTX-801 and Copper (64Cu) Chloride for Adults with Wilson’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepato-lenticular degeneration
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 3B Encoding Shortened Human Atp7B
    • Copper (64Cu) Chloride
    Denmark Germany
Previous Page
1 … 46 47 48 49 50 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!